201
|
Alexander JP, Baker R, Bebek C, Berger BE, Berkelman K, Blanc F, Boisvert V, Cassel DG, Dickson M, Drell PS, Ecklund KM, Ehrlich R, Foland AD, Gaidarev P, Gibbons L, Gittelman B, Gray SW, Hartill DL, Heltsley BK, Hopman PI, Jones CD, Kreinick DL, Lohner M, Magerkurth A, Meyer TO, Mistry NB, Nordberg E, Patterson JR, Peterson D, Riley D, Thayer JG, Thies PG, Valant-Spaight B, Warburton A, Avery P, Prescott C, Rubiera AI, Yelton J, Zheng J, Brandenburg G, Ershov A, Gao YS, Kim DY, Wilson R, Browder TE, Li Y, Rodriguez JL, Yamamoto H, Bergfeld T, Eisenstein BI, Ernst J, Gladding GE, Gollin GD, Hans RM, Johnson E, Karliner I, Marsh MA, Palmer M, Plager C, Sedlack C, Selen M, Thaler JJ, Williams J, Edwards KW, Janicek R, Patel PM, Sadoff AJ, Ammar R, Bean A, Besson D, Davis R, Kwak N, Zhao X, Anderson S, Frolov VV, Kubota Y, Lee SJ, Mahapatra R, O'Neill JJ, Poling R, Riehle T, Smith A, Urheim J, Ahmed S, Alam MS, Athar SB, Jian L, Ling L, Mahmood AH, Saleem M, Timm S, Wappler F, Anastassov A, Duboscq JE, Eckhart E, Gan KK, Gwon C, Hart T, Honscheid K, Hufnagel D, Kagan H, Kass R, Pedlar TK, Schwarthoff H, Thayer JB, von Toerne E, Zoeller MM, Richichi SJ, Severini H, Skubic P, Undrus A, Chen S, Fast J, Hinson JW, Lee J, Menon N, Miller DH, Shibata EI, Shipsey IP, Pavlunin V, Cronin-Hennessy D, Kwon Y, Lyon AL, Thorndike EH, Jessop CP, Marsiske H, Perl ML, Savinov V, Ugolini D, Zhou X, Coan TE, Fadeyev V, Maravin Y, Narsky I, Stroynowski R, Ye J, Wlodek T, Artuso M, Ayad R, Boulahouache C, Bukin K, Dambasuren E, Karamov S, Majumder G, Moneti GC, Mountain R, Schuh S, Skwarnicki T, Stone S, Viehhauser G, Wang JC, Wolf A, Wu J, Kopp S, Csorna SE, Danko I, McLean KW, Márka S, Xu Z, Godang R, Kinoshita K, Lai IC, Schrenk S, Bonvicini G, Cinabro D, McGee S, Perera LP, Zhou GJ, Lipeles E, Schmidtler M, Shapiro A, Sun WM, Weinstein AJ, Würthwein F, Jaffe DE, Masek G, Paar HP, Potter EM, Prell S, Sharma V, Asner DM, Eppich A, Hill TS, Morrison RJ, Briere RA, Behrens BH, Ford WT, Gritsan A, Roy J, Smith JG. Measurement of the relative branching fraction of upsilon(4S) to charged and neutral B-meson pairs. PHYSICAL REVIEW LETTERS 2001; 86:2737-2741. [PMID: 11290027 DOI: 10.1103/physrevlett.86.2737] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/01/2000] [Indexed: 05/23/2023]
Abstract
We analyze 9.7x10(6) B_B pairs recorded with the CLEO detector to determine the production ratio of charged to neutral B-meson pairs produced at the Upsilon(4S) resonance. We measure the rates for B0-->J/psiK((*)0) and B+-->J/psiK((*)+) decays and use the world-average B-meson lifetime ratio to extract the relative widths f(+-) / f(00) = gamma(Upsilon(4S)-->B+B-) / gamma(Upsilon(4S)-->B0 B-0)) = 1.04+/-0.07(stat)+/-0.04(syst). With the assumption that f(+-)+f(00) = 1, we obtain f(00) = 0.49+/-0.02(stat)+/-0.01(syst) and f(+-) = 0.51+/-0.02(stat)+/-0.01(syst). This production ratio and its uncertainty apply to all exclusive B-meson branching fractions measured at the Upsilon(4S) resonance.
Collapse
|
202
|
Anderson S, Frolov VV, Kubota Y, Lee SJ, Mahapatra R, O'Neill JJ, Poling R, Riehle T, Smith A, Stepaniak CJ, Urheim J, Ahmed S, Alam MS, Athar SB, Jian L, Ling L, Saleem M, Timm S, Wappler F, Anastassov A, Duboscq JE, Eckhart E, Gan KK, Gwon C, Hart T, Honscheid K, Hufnagel D, Kagan H, Kass R, Pedlar TK, Schwarthoff H, Thayer JB, von Toerne E, Zoeller MM, Richichi SJ, Severini H, Skubic P, Undrus A, Chen S, Fast J, Hinson JW, Lee J, Miller DH, Shibata EI, Shipsey IP, Pavlunin V, Cronin-Hennessy D, Lyon AL, Thorndike EH, Jessop CP, Marsiske H, Perl ML, Savinov V, Zhou X, Coan TE, Fadeyev V, Maravin Y, Narsky I, Stroynowski R, Ye J, Wlodek T, Artuso M, Ayad R, Boulahouache C, Bukin K, Dambasuren E, Karamov S, Majumder G, Moneti GC, Mountain R, Schuh S, Skwarnicki T, Stone S, Viehhauser G, Wang JC, Wolf A, Wu J, Kopp S, Mahmood AH, Csorna SE, Danko I, McLean KW, Márka S, Xu Z, Godang R, Kinoshita K, Lai IC, Schrenk S, Bonvicini G, Cinabro D, McGee S, Perera LP, Zhou GJ, Lipeles E, Pappas SP, Schmidtler M, Shapiro A, Sun WM, Weinstein AJ, Würthwein F, Jaffe DE, Masek G, Paar HP, Potter EM, Prell S, Sharma V, Asner DM, Eppich A, Hill TS, Morrison RJ, Briere RA, Chen GP, Behrens BH, Ford WT, Gritsan A, Roy J, Smith JG, Alexander JP, Baker R, Bebek C, Berger BE, Berkelman K, Blanc F, Boisvert V, Cassel DG, Dickson M, Drell PS, Ecklund KM, Ehrlich R, Foland AD, Gaidarev P, Gibbons L, Gittelman B, Gray SW, Hartill DL, Heltsley BK, Hopman PI, Jones CD, Kandaswamy J, Kreinick DL, Lohner M, Magerkurth A, Meyer TO, Mistry NB, Nordberg E, Patterson JR, Peterson D, Riley D, Thayer JG, Urner D, Valant-Spaight B, Warburton A, Avery P, Prescott C, Rubiera AI, Yelton J, Zheng J, Brandenburg G, Ershov A, Gao YS, Kim DY, Wilson R, Browder TE, Li Y, Rodriguez JL, Yamamoto H, Bergfeld T, Eisenstein BI, Ernst J, Gladding GE, Gollin GD, Hans RM, Johnson E, Karliner I, Marsh MA, Palmer M, Plager C, Sedlack C, Selen M, Thaler JJ, Williams J, Edwards KW, Janicek R, Patel PM, Sadoff AJ, Ammar R, Bean A, Besson D, Davis R, Kwak N, Zhao X. First observation of the decays B(0) --> D(*-)p_p pi+ and B(0) --> D(*-)p_n. PHYSICAL REVIEW LETTERS 2001; 86:2732-2736. [PMID: 11290026 DOI: 10.1103/physrevlett.86.2732] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/05/2000] [Indexed: 05/23/2023]
Abstract
We report the first observation of exclusive decays of the type B-->D(*)N_NX, where N is a nucleon. Using a sample of 9.7x10(6)B_B pairs collected with the CLEO detector operating at the Cornell Electron Storage Ring, we measure the branching fractions B(B0-->D(*-)p_p pi(+)) = (6.5(+1.3)(-1.2)+/-1.0)x10(-4) and B(B0-->D(*-)p_n) = (14.5(+3.4)(-3.0)+/-2.7)x10(-4). Antineutrons are identified by their annihilation in the CsI electromagnetic calorimeter.
Collapse
|
203
|
Aubert B, Boutigny D, De Bonis I, Gaillard JM, Jeremie A, Karyotakis Y, Lees JP, Robbe P, Tisserand V, Palano A, Chen GP, Chen JC, Qi ND, Rong G, Wang P, Zhu YS, Eigen G, Reinertsen PL, Stugu B, Abbott B, Abrams GS, Borgland AW, Breon AB, Brown DN, Button-Shafer J, Cahn RN, Clark AR, Dardin S, Day C, Dow SF, Elioff T, Fan Q, Gaponenko I, Gill MS, Goozen FR, Gowdy SJ, Gritsan A, Groysman Y, Jacobsen RG, Jared RC, Kadel RW, Kadyk J, Karcher A, Kerth LT, Kipnis I, Kluth S, Kolomensky YG, Kral JF, Lafever R, LeClerc C, Levi ME, Lewis SA, Lionberger C, Liu T, Long M, Lynch G, Marino M, Marks K, Meyer AB, Mokhtarani A, Momayezi M, Nyman M, Oddone PJ, Ohnemus J, Oshatz D, Patton S, Perazzo A, Peters C, Pope W, Pripstein M, Quarrie DR, Rasson JE, Roe NA, Romosan A, Ronan MT, Shelkov VG, Stone R, Telnov AV, von der Lippe H, Weber T, Wenzel WA, Zisman MS, Bright-Thomas PG, Harrison TJ, Hawkes CM, Kirk A, Knowles DJ, O'Neale SW, Watson AT, Watson NK, Deppermann T, Koch H, Krug J, Kunze M, Lewandowski B, Peters K, Schmuecker H, Steinke M, Andress JC, Barlow NR, Bhimji W, Chevalier N, Clark PJ, Cottingham WN, De Groot N, Dyce N, Foster B, Mass A, McFall JD, Wallom D, Wilson FF, Abe K, Hearty C, Mattison TS, McKenna JA, Thiessen D, Camanzi B, Jolly S, McKemey AK, Tinslay J, Blinov VE, Bukin AD, Bukin DA, Buzykaev AR, Dubrovin MS, Golubev VB, Ivanchenko VN, Kolachev GM, Korol AA, Kravchenko EA, Onuchin AP, Salnikov AA, Serednyakov SI, Skovpen YI, Telnov VI, Yushkov AN, Lankford AJ, Mandelkern M, McMahon S, Stoker DP, Ahsan A, Buchanan C, Chun S, MacFarlane DB, Prell S, Rahatlou S, Raven G, Sharma V, Burke S, Campagnari C, Dahmes B, Hale D, Hart PA, Kuznetsova N, Kyre S, Levy SL, Long O, Lu A, Richman JD, Verkerke W, Witherell M, Yellin S, Beringer J, Dorfan DE, Eisner AM, Frey A, Grillo AA, Grothe M, Heusch CA, Johnson RP, Kroeger W, Lockman WS, Pulliam T, Sadrozinski H, Schalk T, Schmitz RE, Schumm BA, Seiden A, Spencer EN, Turri M, Walkowiak W, Williams DC, Chen E, Dubois-Felsmann GP, Dvoretskii A, Hanson JE, Hitlin DG, Metzler S, Oyang J, Porter FC, Ryd A, Samuel A, Weaver M, Yang S, Zhu RY, Devmal S, Geld TL, Jayatilleke S, Jayatilleke SM, Mancinelli G, Meadows BT, Sokoloff MD, Bloom P, Fahey S, Ford WT, Gaede F, van Hoek WC, Johnson DR, Michael AK, Nauenberg U, Olivas A, Park H, Rankin P, Roy J, Sen S, Smith JG, Wagner DL, Blouw J, Harton JL, Krishnamurthy M, Soffer A, Toki WH, Warner DW, Wilson RJ, Zhang J, Brandt T, Brose J, Colberg T, Dahlinger G, Dickopp M, Dubitzky RS, Eckstein P, Futterschneider H, Krause R, Maly E, Müller-Pfefferkorn R, Otto S, Schubert KR, Schwierz R, Spaan B, Wilden L, Behr L, Bernard D, Bonneaud GR, Brochard F, Cohen-Tanugi J, Ferrag S, Fouque G, Gastaldi F, Matricon P, Mora de Freitas P, Renard C, Roussot E, T'Jampens S, Thiebaux C, Vasileiadis G, Verderi M, Anjomshoaa A, Bernet R, Di Lodovico F, Khan A, Muheim F, Playfer S, Swain JE, Falbo M, Bozzi C, Dittongo S, Folegani M, Piemontese L, Treadwell E, Anulli F, Baldini-Ferroli R, Calcaterra A, de Sangro R, Falciai D, Finocchiaro G, Patteri P, Peruzzi IM, Piccolo M, Xie Y, Zallo A, Bagnasco S, Buzzo A, Contri R, Crosetti G, Lo Vetere M, Macri M, Monge MR, Pallavicini M, Passaggio S, Pastore FC, Patrignani C, Pia MG, Robutti E, Santroni A, Morii M, Bartoldus R, Dignan T, Hamilton R, Mallik U, Cochran J, Crawley HB, Fischer PA, Lamsa J, McKay R, Meyer WT, Rosenberg EI, Albert JN, Beigbeder C, Benkebil M, Breton D, Cizeron R, Du S, Grosdidier G, Hast C, Höcker A, LePeltier V, Lutz AM, Plaszczynski S, Schune MH, Trincaz-Duvoid S, Truong K, Valassi A, Wormser G, Bionta RM, Brigljević V, Brooks A, Fackler O, Fujino D, Lange DJ, Mugge M, O'Connor TG, Pedrotti B, Shi X, van Bibber K, Wenaus TJ, Wright DM, Wuest CR, Yamamoto B, Carroll M, Fry JR, Gabathuler E, Gamet R, George M, Kay M, Payne DJ, Sloane RJ, Touramanis C, Aspinwall ML, Bowerman DA, Dauncey PD, Egede U, Eschrich I, Gunawardane NJ, Martin R, Nash JA, Price DR, Sanders P, Smith D, Azzopardi DE, Back JJ, Dixon P, Harrison PF, Newman-Coburn D, Potter RJ, Shorthouse HW, Strother P, Vidal PB, Williams MI, Cowan G, George S, Green MG, Kurup A, Marker CE, McGrath P, McMahon TR, Salvatore F, Scott I, Vaitsas G, Brown D, Davis CL, Ford K, Li Y, Pavlovich J, Allison J, Barlow RJ, Boyd JT, Fullwood J, Jackson F, Lafferty GD, Savvas N, Simopoulos ET, Thompson RJ, Weatherall JH, Bard R, Farbin A, Jawahery A, Lillard V, Olsen J, Roberts DA, Schieck JR, Blaylock G, Dallapiccola C, Flood KT, Hertzbach SS, Kofler R, Lin CS, Staengle H, Willocq S, Wittlin J, Brau B, Cowan R, Sciolla G, Taylor F, Yamamoto RK, Britton DI, Milek M, Patel PM, Trischuk J, Lanni F, Palombo F, Bauer JM, Booke M, Cremaldi L, Eschenberg V, Kroeger R, Reep M, Reidy J, Sanders DA, Summers DJ, Beaulieu M, Martin JP, Nief JY, Seitz R, Taras P, Zacek V, Nicholson H, Sutton CS, Cavallo N, Cartaro C, De Nardo G, Fabozzi F, Gatto C, Lista L, Paolucci P, Piccolo D, Sciacca C, LoSecco JM, Alsmiller JR, Gabriel TA, Handler T, Heck J, Brau JE, Frey R, Iwasaki M, Sinev NB, Strom D, Borsato E, Colecchia F, Dal Corso F, Galeazzi F, Margoni M, Marzolla M, Michelon G, Morandin M, Posocco M, Rotondo M, Simonetto F, Stroili R, Torassa E, Voci C, Bailly P, Benayoun M, Briand H, Chauveau J, David P, De La Vaissière C, Del Buono L, Genat JF, Hamon O, Le Diberder F, Lebbolo H, Leruste P, Lory J, Martin L, Roos L, Stark J, Versillé S, Zhang B, Manfredi PF, Ratti L, Re V, Speziali V, Frank ED, Gladney L, Guo QH, Panetta JH, Angelini C, Batignani G, Bettarini S, Bondioli M, Bosi F, Carpinelli M, Forti F, Giorgi MA, Lusiani A, Martinez-Vidal F, Morganti M, Neri N, Paoloni E, Rama M, Rizzo G, Sandrelli F, Simi G, Triggiani G, Walsh J, Hairre M, Judd D, Paick K, Turnbull L, Wagoner DE, Albert J, Bula C, Fernholz R, Lu C, McDonald KT, Miftakov V, Sands B, Schaffner SF, Smith AJ, Tumanov A, Varnes EW, Bronzini F, Buccheri A, Bulfon C, Cavoto G, del Re D, Faccini R, Ferrarotto F, Ferroni F, Fratini K, Lamanna E, Leonardi E, Mazzoni MA, Morganti S, Piredda G, Safai Tehrani F, Serra M, Voena C, Waldi R, Jacques PF, Kalelkar M, Plano RJ, Adye T, Claxton B, Franek B, Galagedera S, Geddes NI, Gopal GP, Lidbury J, Xella SM, Aleksan R, Besson P, Bourgeois P, De Domenico G, Emery S, Gaidot A, Ganzhur SF, Gosset L, Hamel de Monchenault G, Kozanecki W, Langer M, London GW, Mayer B, Serfass B, Vasseur G, Yeche C, Zito M, Copty N, Purohit MV, Singh H, Yumiceva FX, Adam I, Anthony PL, Aston D, Baird K, Bartelt J, Becla J, Bell R, Bloom E, Boeheim CT, Boyarski AM, Boyce RF, Bulos F, Burgess W, Byers B, Calderini G, Claus R, Convery MR, Coombes R, Cottrell L, Coupal DP, Coward DH, Craddock WW, DeStaebler H, Dorfan J, Doser M, Dunwoodie W, Ecklund S, Fieguth TH, Field RC, Freytag DR, Glanzman T, Godfrey GL, Grosso P, Haller G, Hanushevsky A, Harris J, Hasan A, Hewett JL, Himel T, Huffer ME, Innes WR, Jessop CP, Kawahara H, Keller L, Kelsey MH, Kim P, Klaisner LA, Kocian ML, Krebs HJ, Kunz PF, Langenegger U, Langeveld W, Leith DW, Louie SK, Luitz S, Luth V, Lynch HL, MacDonald J, Manzin G, Mariske H, McCulloch M, McShurley D, Menke S, Messner R, Metcalfe S, Moffeit KC, Mount R, Muller DR, Nelson D, Nordby M, O'Grady CP, O'Neill FG, Oxoby G, Pavel T, Perl J, Petrak S, Putallaz G, Quinn H, Raines PE, Ratcliff BN, Reif R, Robertson SH, Rochester LS, Roodman A, Russell JJ, Sapozhnikov L, Saxton OH, Schietinger T, Schindler RH, Schwiening J, Seeman JT, Serbo VV, Skarpass K, Snyder A, Soha A, Spanier SM, Stahl A, Stelzer J, Su D, Sullivan MK, Talby M, Tanaka HA, Va'vra J, Wagner SR, Weinstein AJ, White JL, Wienands U, Wisniewski WJ, Young CC, Zioulas G, Burchat PR, Cheng CH, Kirkby D, Meyer TI, Roat C, De Silva A, Henderson R, Berridge S, Bugg W, Cohn H, Hart E, Weidemann AW, Benninger T, Izen JM, Kitayama I, Lou XC, Turcotte M, Bianchi F, Bona M, Di Girolamo B, Gamba D, Smol A, Zanin D, Bosisio L, Della Ricca G, Lanceri L, Pompili A, Poropat P, Vuagnin G, Panvini RS, Brown CM, Kowalewski R, Roney JM, Band HR, Charles E, Dasu S, Elmer P, Hu H, Johnson JR, Nielsen J, Orejudos W, Pan Y, Prepost R, Scott IJ, von Wimmersperg-Toeller JH, Wu SL, Yu Z, Zobernig H, Kordich TM, Moore TB, Neal H. Measurement of CP-violating asymmetries in B0 decays to CP eigenstates. PHYSICAL REVIEW LETTERS 2001; 86:2515-2522. [PMID: 11289970 DOI: 10.1103/physrevlett.86.2515] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/12/2001] [Indexed: 05/23/2023]
Abstract
We present measurements of time-dependent CP-violating asymmetries in neutral B decays to several CP eigenstates. The measurement uses a data sample of 23x10(6) Upsilon(4S)-->BbarB decays collected by the BABAR detector at the PEP-II asymmetric B Factory at SLAC. In this sample, we find events in which one neutral B meson is fully reconstructed in a CP eigenstate containing charmonium and the flavor of the other neutral B meson is determined from its decay products. The amplitude of the CP-violating asymmetry, which in the standard model is proportional to sin2beta, is derived from the decay time distributions in such events. The result is sin2beta = 0.34+/-0.20 (stat)+/-0.05 (syst).
Collapse
|
204
|
Mahmood AH, Csorna SE, Danko I, McLean KW, Márka S, Xu Z, Godang R, Kinoshita K, Lai IC, Schrenk S, Bonvicini G, Cinabro D, McGee S, Perera LP, Zhou GJ, Lipeles E, Pappas SP, Schmidtler M, Shapiro A, Sun WM, Weinstein AJ, Würthwein F, Jaffe DE, Masek G, Paar HP, Potter EM, Prell S, Sharma V, Asner DM, Eppich A, Hill TS, Morrison RJ, Nelson HN, Briere RA, Chen GP, Behrens BH, Ford WT, Gritsan A, Roy J, Smith JG, Alexander JP, Baker R, Bebek C, Berger BE, Berkelman K, Blanc F, Boisvert V, Cassel DG, Dickson M, Drell PS, Ecklund KM, Ehrlich R, Foland AD, Gaidarev P, Galik RS, Gibbons L, Gittelman B, Gray SW, Hartill DL, Heltsley BK, Hopman PI, Jones CD, Kandaswamy J, Kreinick DL, Lohner M, Magerkurth A, Meyer TO, Mistry NB, Nordberg E, Patterson JR, Peterson D, Riley D, Thayer JG, Urner D, Valant-Spaight B, Warburton A, Avery P, Prescott C, Rubiera AI, Yelton J, Zheng J, Brandenburg G, Ershov A, Gao YS, Kim DY, Wilson R, Browder TE, Li Y, Rodriguez JL, Yamamoto H, Bergfeld T, Eisenstein BI, Ernst J, Gladding GE, Gollin GD, Hans RM, Johnson E, Karliner I, Marsh MA, Palmer M, Plager C, Sedlack C, Selen M, Thaler JJ, Williams J, Edwards KW, Janicek R, Patel PM, Sadoff AJ, Ammar R, Bean A, Besson D, Davis R, Kwak N, Zhao X, Anderson S, Frolov VV, Kubota Y, Lee SJ, Mahapatra R, O'Neill JJ, Poling R, Riehle T, Smith A, Stepaniak CJ, Urheim J, Ahmed S, Alam MS, Athar SB, Jian L, Ling L, Saleem M, Timm S, Wappler F, Anastassov A, Duboscq JE, Eckhart E, Gan KK, Gwon C, Hart T, Honscheid K, Hufnagel D, Kagan H, Kass R, Pedlar TK, Schwarthoff H, Thayer JB, von Toerne E, Zoeller MM, Richichi SJ, Severini H, Skubic P, Undrus A, Chen S, Fast J, Hinson JW, Lee J, Miller DH, Shibata EI, Shipsey IP, Pavlunin V, Cronin-Hennessy D, Lyon AL, Thorndike EH, Jessop CP, Marsiske H, Perl ML, Savinov V, Zhou X, Coan TE, Fadeyev V, Maravin Y, Narsky I, Stroynowski R, Ye J, Wlodek T, Artuso M, Ayad R, Boulahouache C, Bukin K, Dambasuren E, Karamov S, Majumder G, Moneti GC, Mountain R, Schuh S, Skwarnicki T, Stone S, Viehhauser G, Wang JC, Wolf A, Wu J, Kopp S. Measurement of the lambda(+)(c) lifetime. PHYSICAL REVIEW LETTERS 2001; 86:2232-2236. [PMID: 11289897 DOI: 10.1103/physrevlett.86.2232] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/15/2000] [Indexed: 05/23/2023]
Abstract
The Lambda+c lifetime is measured using 9.0 fb(-1) of e+e- annihilation data collected on or just below the Upsilon(4S) resonance with the CLEO II.V detector at CESR. Using an unbinned maximum likelihood fit, the Lambda+c lifetime is measured to be 179.6+/-6.9(stat)+/-4.4(syst) fs. The precision of this colliding beam measurement is comparable to other measurements, which are based on fixed-target experiments, with different systematic uncertainties.
Collapse
|
205
|
Abstract
BACKGROUND Since 1992, we have been using a 6-MV linear accelerator instead of a cobalt machine. The aim of the study is to evaluate the impact of this on neck control, particularly on postoperative patients in which subcutaneous tissues are at risk. METHOD A retrospective study including all of 1,452 consecutive patients treated by definitive or postoperative radiotherapy between 1989 and 1997. All stages and subsites of the head/neck were included. Local and neck control were evaluated by the Kaplan Meier method, and comparisons were made between the cobalt and the 6-MV subgroups with a subsequent Cox analysis. For neck control analysis, the postoperative patients were divided in low and high risk (extracapsular extension [ECE], >two nodes, or T4). RESULTS Radical radiotherapy: A better local control (LC) is observed with 6 MV than with cobalt, but neck control was similar. Postoperative radiotherapy: A better LC is observed with 6 MV. In high-risk patients, the neck control was higher for the cobalt group (79%) vs 60% for the 6-MV group (p = .09 and .03 in a Cox model). CONCLUSION In postoperative patients at high risk for neck relapse, cobalt seems to give a better neck control. We are currently doing a prospective study in which a bolus is added for half the treatment when patients at high risk for neck relapse are treated with 6 MV.
Collapse
|
206
|
Ammar R, Bean A, Besson D, Davis R, Kwak N, Zhao X, Anderson S, Frolov VV, Kubota Y, Lee SJ, Mahapatra R, O'Neill JJ, Poling R, Riehle T, Smith A, Stepaniak CJ, Urheim J, Ahmed S, Alam MS, Athar SB, Jian L, Ling L, Saleem M, Timm S, Wappler F, Anastassov A, Duboscq JE, Eckhart E, Gan KK, Gwon C, Hart T, Honscheid K, Hufnagel D, Kagan H, Kass R, Pedlar TK, Schwarthoff H, Thayer JB, von Toerne E, Zoeller MM, Richichi SJ, Severini H, Skubic P, Undrus A, Chen S, Fast J, Hinson JW, Lee J, Miller DH, Shibata EI, Shipsey IP, Pavlunin V, Cronin-Hennessy D, Lyon AL, Thorndike EH, Jessop CP, Marsiske H, Perl ML, Savinov V, Zhou X, Coan TE, Fadeyev V, Maravin Y, Narsky I, Stroynowski R, Ye J, Wlodek T, Artuso M, Ayad R, Boulahouache C, Bukin K, Dambasuren E, Karamov S, Majumder G, Moneti GC, Mountain R, Schuh S, Skwarnicki T, Stone S, Viehhauser G, Wang JC, Wolf A, Wu J, Kopp S, Mahmood AH, Csorna SE, Danko I, McLean KW, Márka S, Xu Z, Godang R, Kinoshita K, Lai IC, Schrenk S, Bonvicini G, Cinabro D, McGee S, Perera LP, Zhou GJ, Lipeles E, Pappas SP, Schmidtler M, Shapiro A, Sun WM, Weinstein AJ, Würthwein F, Jaffe DE, Masek G, Paar HP, Potter EM, Prell S, Sharma V, Asner DM, Eppich A, Hill TS, Morrison RJ, Briere RA, Chen GP, Behrens BH, Ford WT, Gritsan A, Roy J, Smith JG, Alexander JP, Baker R, Bebek C, Berger BE, Berkelman K, Blanc F, Boisvert V, Cassel DG, Dickson M, Drell PS, Ecklund KM, Ehrlich R, Foland AD, Gaidarev P, Galik RS, Gibbons L, Gittelman B, Gray SW, Hartill DL, Heltsley BK, Hopman PI, Jones CD, Kreinick DL, Lohner M, Magerkurth A, Meyer TO, Mistry NB, Nordberg E, Patterson JR, Peterson D, Riley D, Thayer JG, Urner D, Valant-Spaight B, Warburton A, Avery P, Prescott C, Rubiera AI, Yelton J, Zheng J, Brandenburg G, Ershov A, Gao YS, Kim DY, Wilson R, Browder TE, Li Y, Rodriguez JL, Yamamoto H, Bergfeld T, Eisenstein BI, Ernst J, Gladding GE, Gollin GD, Hans RM, Johnson E, Karliner I, Marsh MA, Palmer M, Plager C, Sedlack C, Selen M, Thaler JJ, Williams J, Edwards KW, Janicek R, Patel PM, Sadoff AJ. First observation of the sigma(*+)(c) baryon and a new measurement of the sigma(*+)(c) mass. PHYSICAL REVIEW LETTERS 2001; 86:1167-1170. [PMID: 11178035 DOI: 10.1103/physrevlett.86.1167] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/19/2000] [Indexed: 05/23/2023]
Abstract
Using data recorded with the CLEO II and CLEO II.V detector configurations at the Cornell Electron Storage Rings, we report the first observation and mass measurement of the Sigma(*+)(c) charmed baryon, and an updated measurement of the mass of the Sigma(+)(c) baryon. We find M(Sigma(*+)(c))-M(Lambda(+)(c)) = (231.0+/-1.1+/-2.0) MeV, and M(Sigma(+)(c))-M(Lambda(+)(c)) = (166.4+/-0.2+/-0.3) MeV, where the errors are statistical and systematic, respectively.
Collapse
|
207
|
Roy J, Kazi M, Hedin U, Thyberg J. Phenotypic modulation of arterial smooth muscle cells is associated with prolonged activation of ERK1/2. Differentiation 2001; 67:50-8. [PMID: 11270123 DOI: 10.1046/j.1432-0436.2001.067001050.x] [Citation(s) in RCA: 29] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/21/2022]
Abstract
Arterial smooth muscle cells grown in primary culture on a substrate of fibronectin in serum-free medium are converted from a contractile to a synthetic phenotype. This process is dependent on integrin signaling and includes a major structural reorganization with loss of myofilaments and formation of a large secretory apparatus. Functionally, the cells lose their contractility and become competent to migrate, secrete extracellular matrix components, and proliferate in response to growth factor stimulation. Here, it is demonstrated that the mitogen-activated protein kinases ERK1/2 play a vital role in the fibronectin-mediated modification of rat aortic smooth muscle cells. Immunoblotting showed that phosphorylated ERK1/2 (p44/p42) were expressed throughout the period when the change in phenotypic properties of the cells took place. Moreover, phosphorylated ERK1/2 accumulated in the nucleus as revealed by immunocytochemical staining. Additional support for an active role of ERK1/2 in the shift in smooth muscle phenotype was obtained by the finding that PD98059, an inhibitor of the upstream kinase MEK1, potently suppressed both the expression of phosphorylated ERK1/2 and the fine structural rebuilding of the cells. In conclusion, the observations point to an important and multifaceted role of ERK1/2 in the regulation of differentiated properties and growth of vascular smooth muscle cells.
Collapse
|
208
|
Edwards KW, Janicek R, Patel PM, Sadoff AJ, Ammar R, Bean A, Besson D, Davis R, Kwak N, Zhao X, Anderson S, Frolov VV, Kubota Y, Lee SJ, Mahapatra R, O'Neill JJ, Poling R, Riehle T, Smith A, Stepaniak CJ, Urheim J, Ahmed S, Alam MS, Athar SB, Jian L, Ling L, Saleem M, Timm S, Wappler F, Anastassov A, Duboscq JE, Eckhart E, Gan KK, Gwon C, Hart T, Honscheid K, Hufnagel D, Kagan H, Kass R, Pedlar TK, Schwarthoff H, Thayer JB, Zoeller MM, Richichi SJ, Severini H, Skubic P, Undrus A, Chen S, Fast J, Hinson JW, Lee J, Miller DH, Shibata EI, Shipsey IP, Pavlunin V, Cronin-Hennessy D, Lyon AL, Thorndike EH, Jessop CP, Marsiske H, Perl ML, Savinov V, Ugolini D, Zhou X, Coan TE, Fadeyev V, Maravin Y, Narsky I, Stroynowski R, Ye J, Wlodek T, Artuso M, Ayad R, Boulahouache C, Bukin K, Dambasuren E, Karamov S, Majumder G, Moneti GC, Mountain R, Schuh S, Skwarnicki T, Stone S, Viehhauser G, Wang JC, Wolf A, Wu J, Kopp S, Mahmood AH, Csorna SE, Danko I, McLean KW, Márka S, Xu Z, Godang R, Kinoshita K, Lai IC, Schrenk S, Bonvicini G, Cinabro D, McGee S, Perera LP, Zhou GJ, Lipeles E, Pappas SP, Schmidtler M, Shapiro A, Sun WM, Weinstein AJ, Würthwein F, Jaffe DE, Masek G, Paar HP, Potter EM, Prell S, Sharma V, Asner DM, Eppich A, Hill TS, Morrison RJ, Briere RA, Behrens BH, Ford WT, Gritsan A, Roy J, Smith JG, Alexander JP, Baker R, Bebek C, Berger BE, Berkelman K, Blanc F, Boisvert V, Cassel DG, Dickson M, Drell PS, Ecklund KM, Ehrlich R, Foland AD, Gaidarev P, Gibbons L, Gittelman B, Gray SW, Hartill DL, Heltsley BK, Hopman PI, Jones CD, Kreinick DL, Lohner M, Magerkurth A, Meyer TO, Mistry NB, Nordberg E, Patterson JR, Peterson D, Riley D, Thayer JG, Thies PG, Valant-Spaight B, Warburton A, Avery P, Prescott C, Rubiera AI, Yelton J, Zheng J, Brandenburg G, Ershov A, Gao YS, Kim DY, Wilson R, Browder TE, Li Y, Rodriguez JL, Yamamoto H, Bergfeld T, Eisenstein BI, Ernst J, Gladding GE, Gollin GD, Hans RM, Johnson E, Karliner I, Marsh MA, Palmer M, Plager C, Sedlack C, Selen M, Thaler JJ, Williams J. Study of B Decays to Charmonium States: B-->eta(c)K and B --> chi(c0)K. PHYSICAL REVIEW LETTERS 2001; 86:30-34. [PMID: 11136086 DOI: 10.1103/physrevlett.86.30] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/07/2000] [Indexed: 05/23/2023]
Abstract
In a sample of 9.66x10(6)B&Bmacr; pairs collected with the CLEO detector we make the first observation of B decays to an eta(c) and a kaon. We measure branching fractions B(B+-->eta(c)K+) = (0.69(+0.26)(-0.21)+/-0.08+/-0.20)x10(-3) and B(B degrees -->eta(c)K degrees ) = (1.09(+0.55)(-0.42)+/-0.12+/-0.31)x10(-3), where the first error is statistical, the second is systematic, and the third is from the eta(c) branching fraction uncertainty. From these we extract the eta(c) decay constant in the factorization approximation, f(eta(c)) = 335+/-75 MeV. We also search for B decays to a chi(c0) and a kaon. No evidence for a signal is found and we set 90% C.L. upper limits: B(B+-->chi(c0)K+)<4.8x10(-4) and B(B degrees -->chi(c0)K degrees )<5.0x10(-4).
Collapse
|
209
|
Roy J, Mitra K, Gangopadhyay PK, Das S, Roy T, Maity B. A case of foot dystonia with peripheral lesion. Neurol India 2000; 48:404-5. [PMID: 11146616] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/18/2023]
|
210
|
Abstract
Multiple outcomes are often used to properly characterize an effect of interest. This paper proposes a latent variable model for the situation where repeated measures over time are obtained on each outcome. These outcomes are assumed to measure an underlying quantity of main interest from different perspectives. We relate the observed outcomes using regression models to a latent variable, which is then modeled as a function of covariates by a separate regression model. Random effects are used to model the correlation due to repeated measures of the observed outcomes and the latent variable. An EM algorithm is developed to obtain maximum likelihood estimates of model parameters. Unit-specific predictions of the latent variables are also calculated. This method is illustrated using data from a national panel study on changes in methadone treatment practices.
Collapse
|
211
|
Boivin G, Bélanger R, Delage R, Béliveau C, Demers C, Goyette N, Roy J. Quantitative analysis of cytomegalovirus (CMV) viremia using the pp65 antigenemia assay and the COBAS AMPLICOR CMV MONITOR PCR test after blood and marrow allogeneic transplantation. J Clin Microbiol 2000; 38:4356-60. [PMID: 11101564 PMCID: PMC87605 DOI: 10.1128/jcm.38.12.4356-4360.2000] [Citation(s) in RCA: 54] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
The performance of a commercially available qualitative PCR test for plasma (AMPLICOR CMV Test; Roche Diagnostics) and a quantitative PCR test for plasma and leukocytes (COBAS AMPLICOR CMV MONITOR Test; Roche Diagnostics) was evaluated with samples from 50 blood or marrow allogeneic transplant recipients who received short courses of sequential ganciclovir therapy (2 weeks intravenously followed by 2 weeks orally) based on a positive cytomegalovirus (CMV) pp65 antigenemia (AG) assay. The number of persons with a positive CMV test was significantly higher for leukocyte-based assays (AG, 67.5%; PCR, 62.5%) compared to both quantitative and qualitative PCR tests of plasma (42.5 and 35%, respectively). One person developed CMV disease during the study despite a negative AG assay; in this particular case, all PCR assays were found to be positive 10 days before his death. There was a trend for earlier positivity after transplantation and more rapid negativity after initiation of ganciclovir for the tests performed on leukocytes. The mean number of CMV copies as assessed by PCR was significantly higher in leukocytes than in plasma (P = 0.02). Overall, excellent agreement (kappa coefficient, >0.75) was found only between the two PCR assays (qualitative and quantitative) based on plasma. These results suggest that either the pp65 AG assay or the COBAS AMPLICOR CMV MONITOR Test using leukocytes could be used to safely monitor CMV viremia in related allogeneic blood or marrow transplant recipients. Such a strategy will result in preemptive treatment for about two-thirds of the persons with a relatively low rate (<33%) of secondary viremic episodes following short courses of ganciclovir therapy.
Collapse
|
212
|
Veronesi B, Oortgiesen M, Roy J, Carter JD, Simon SA, Gavett SH. Vanilloid (capsaicin) receptors influence inflammatory sensitivity in response to particulate matter. Toxicol Appl Pharmacol 2000; 169:66-76. [PMID: 11076698 DOI: 10.1006/taap.2000.9040] [Citation(s) in RCA: 39] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
The signs of airway inflammation and hyperresponsiveness that occur in animals exposed to air pollutants are often strain- and species-specific. To investigate the underlying causes of this phenomenon, BALB/c and C57bl/6 mice were exposed intratracheally to residual oil fly ash (ROFA, 3 mg/kg) and examined after 24 h for signs of airway inflammation. BALB/c showed significantly higher numbers of neutrophils and increased airway hyperresponsiveness in response to methacholine challenge, whereas B6 mice showed no significant change in either inflammatory endpoint. To determine the underlying cause of this strain specificity, cultures of dorsal root ganglion (DRG) sensory neurons, which innervate the upper airways in situ, were explanted from both BALB/c and B6 fetal mice. After 5-7 days in culture, they were exposed to ROFA, other urban and industrial particulate matter (PM; e.g., oil fly ash, woodstove, Mt. St. Helen, St. Louis, Ottawa, coal fly ash) or to prototype irritants (e.g., capsaicin 3-10 microM, pH 5.0 and 6.5). In all instances (except for woodstove), DRG neurons from BALB/c mice released significantly higher levels of the pro-inflammatory cytokine IL-6 into their nutrient media relative to neurons from B6 mice. This cytokine release could be significantly reduced for all PM treated cultures (except woodstove) by pretreatment of cultures with capsazepine (CPZ), a competitive antagonist of vanilloid receptors. DRG neurons, cultured from BALB/c and B6 neonates, were loaded with Fluo-3 AM and exposed to the prototype irritants, acid pH (5.0, 6.5), or capsaicin (3, 10 microM). Analysis of their increases in intracellular calcium showed that significantly higher numbers of BALB/c neurons responded to these prototype irritants, relative to B6 neurons. Morphometric analysis of BALB/c neurons, histochemically stained with cobalt to label neurons bearing capsaicin-sensitive receptors, showed a significantly higher level of stained neurons relative to B6 neurons. Finally, semiquantitative RT-PCR showed a higher expression of VR1 receptor mRNA in DRG and spinal cord taken from neonatal BALB/c mice relative to B6 mice. Taken together, these data suggest that capsaicin and acid-sensitive irritant receptors, located on somatosensory cell bodies and their nerve fiber terminals, subserve PM-induced airway inflammation and are quantitatively different in responsive and nonresponsive mouse strains.
Collapse
MESH Headings
- Air Pollutants/toxicity
- Animals
- Animals, Newborn
- Bronchial Hyperreactivity/chemically induced
- Bronchial Hyperreactivity/physiopathology
- Capsaicin/metabolism
- Carbon/administration & dosage
- Carbon/toxicity
- Cell Survival/drug effects
- Cells, Cultured
- Coal Ash
- Dose-Response Relationship, Drug
- Female
- Fetus/cytology
- Ganglia, Spinal/cytology
- Ganglia, Spinal/drug effects
- Ganglia, Spinal/embryology
- Ganglia, Spinal/metabolism
- Interleukin-6/metabolism
- Intubation, Intratracheal
- Mice
- Mice, Inbred BALB C
- Mice, Inbred C57BL
- Neurons, Afferent/cytology
- Neurons, Afferent/drug effects
- Neurons, Afferent/metabolism
- Particulate Matter
- Pregnancy
- RNA/metabolism
- Receptors, Drug/genetics
- Receptors, Drug/metabolism
- Reverse Transcriptase Polymerase Chain Reaction
- Species Specificity
Collapse
|
213
|
Brandenburg G, Ershov A, Gao YS, Kim DY, Wilson R, Browder TE, Li Y, Rodriguez JL, Yamamoto H, Bergfeld T, Eisenstein BI, Ernst J, Gladding GE, Gollin GD, Hans RM, Johnson E, Karliner I, Marsh MA, Palmer M, Plager C, Sedlack C, Selen M, Thaler JJ, Williams J, Edwards KW, Janicek R, Patel PM, Sadoff AJ, Ammar R, Bean A, Besson D, Davis R, Kwak N, Zhao X, Anderson S, Frolov VV, Kubota Y, Lee SJ, Mahapatra R, O'Neill JJ, Poling R, Riehle T, Smith A, Stepaniak CJ, Urheim J, Ahmed S, Alam MS, Athar SB, Jian L, Ling L, Saleem M, Timm S, Wappler F, Anastassov A, Duboscq JE, Eckhart E, Gan KK, Gwon C, Hart T, Honscheid K, Hufnagel D, Kagan H, Kass R, Pedlar TK, Schwarthoff H, Thayer JB, von Toerne E, Zoeller MM, Richichi SJ, Severini H, Skubic P, Undrus A, Chen S, Fast J, Hinson JW, Lee J, Miller DH, Shibata EI, Shipsey IP, Pavlunin V, Cronin-Hennessy D, Lyon AL, Thorndike EH, Jessop CP, Marsiske H, Perl ML, Savinov V, Ugolini D, Zhou X, Coan TE, Fadeyev V, Maravin Y, Narsky I, Stroynowski R, Ye J, Wlodek T, Artuso M, Ayad R, Boulahouache C, Bukin K, Dambasuren E, Karamov S, Majumder G, Moneti GC, Mountain R, Schuh S, Skwarnicki T, Stone S, Viehhauser G, Wang JC, Wolf A, Wu J, Kopp S, Mahmood AH, Csorna SE, Danko I, McLean KW, Márka S, Xu Z, Godang R, Kinoshita K, Lai IC, Schrenk S, Bonvicini G, Cinabro D, McGee S, Perera LP, Zhou GJ, Lipeles E, Pappas SP, Schmidtler M, Shapiro A, Sun WM, Weinstein AJ, Würthwein F, Jaffe DE, Masek G, Paar HP, Potter EM, Prell S, Sharma V, Asner DM, Eppich A, Hill TS, Morrison RJ, Briere RA, Ferguson T, Vogel H, Behrens BH, Ford WT, Gritsan A, Roy J, Smith JG, Alexander JP, Baker R, Bebek C, Berger BE, Berkelman K, Blanc F, Boisvert V, Cassel DG, Dickson M, Drell PS, Ecklund KM, Ehrlich R, Foland AD, Gaidarev P, Galik RS, Gibbons L, Gittelman B, Gray SW, Hartill DL, Heltsley BK, Hopman PI, Jones CD, Kreinick DL, Lohner M, Magerkurth A, Meyer TO, Mistry NB, Nordberg E, Patterson JR, Peterson D, Riley D, Thayer JG, Thies PG, Urner D, Valant-Spaight B, Warburton A, Avery P, Prescott C, Rubiera AI, Yelton J, Zheng J. Measurements of the mass, total width, and two-photon partial width of the eta(c) meson. PHYSICAL REVIEW LETTERS 2000; 85:3095-3099. [PMID: 11019275 DOI: 10.1103/physrevlett.85.3095] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/20/2000] [Indexed: 05/23/2023]
Abstract
Using 13.4 fb(-1) of data collected with the CLEO detector at the Cornell Electron Storage Ring, we have observed 300 events for the two-photon production of ground-state pseudoscalar charmonium in the decay eta(c)-->K(0)(S)K-/+pi(+/-). We have measured the eta(c) mass to be [2980.4+/-2.3 (stat)+/-0.6 (syst)] MeV and its full width as [27.0+/-5.8 (stat)+/-1.4 (syst)] MeV. We have determined the two-photon partial width of the eta(c) meson to be [7.6+/-0.8 (stat)+/-0.4 (syst)+/-2.3 (br)] keV, with the last uncertainty associated with the decay branching fraction.
Collapse
|
214
|
Jessop CP, Marsiske H, Perl ML, Savinov V, Ugolini D, Zhou X, Coan TE, Fadeyev V, Maravin Y, Narsky I, Stroynowski R, Ye J, Wlodek T, Artuso M, Ayad R, Boulahouache C, Bukin K, Dambasuren E, Karamov S, Majumder G, Moneti GC, Mountain R, Schuh S, Skwarnicki T, Stone S, Viehhauser G, Wang JC, Wolf A, Wu J, Kopp S, Csorna SE, Danko I, McLean KW, Márka S, Xu Z, Godang R, Kinoshita K, Lai IC, Schrenk S, Bonvicini G, Cinabro D, McGee S, Perera LP, Zhou GJ, Lipeles E, Schmidtler M, Shapiro A, Sun WM, Weinstein AJ, Würthwein F, Jaffe DE, Masek G, Paar HP, Potter EM, Prell S, Sharma V, Asner DM, Eppich A, Hill TS, Morrison RJ, Nelson HN, Briere RA, Behrens BH, Ford WT, Gritsan A, Roy J, Smith JG, Alexander JP, Baker R, Bebek C, Berger BE, Berkelman K, Blanc F, Boisvert V, Cassel DG, Dickson M, Drell PS, Ecklund KM, Ehrlich R, Foland AD, Gaidarev P, Gibbons L, Gittelman B, Gray SW, Hartill DL, Heltsley BK, Hopman PI, Jones CD, Kreinick DL, Lohner M, Magerkurth A, Meyer TO, Mistry NB, Nordberg E, Patterson JR, Peterson D, Riley D, Thayer JG, Thies PG, Valant-Spaight B, Warburton A, Avery P, Prescott C, Rubiera AI, Yelton J, Zheng J, Brandenburg G, Ershov A, Gao YS, Kim DY, Wilson R, Browder TE, Li Y, Rodriguez JL, Yamamoto H, Bergfeld T, Eisenstein BI, Ernst J, Gladding GE, Gollin GD, Hans RM, Johnson E, Karliner I, Marsh MA, Palmer M, Plager C, Sedlack C, Selen M, Thaler JJ, Williams J, Edwards KW, Janicek R, Patel PM, Sadoff AJ, Ammar R, Bean A, Besson D, Davis R, Kwak N, Zhao X, Anderson S, Frolov VV, Kubota Y, Lee SJ, Mahapatra R, O'Neill JJ, Poling R, Riehle T, Smith A, Urheim J, Ahmed S, Alam MS, Athar SB, Jian L, Ling L, Mahmood AH, Saleem M, Timm S, Wappler F, Anastassov A, Duboscq JE, Gan KK, Gwon C, Hart T, Honscheid K, Hufnagel D, Kagan H, Kass R, Pedlar TK, Schwarthoff H, Thayer JB, von Toerne E, Zoeller MM, Richichi J, Severini H, Skubic P, Undrus A, Chen S, Fast J, Hinson JW, Lee J, Menon N, Miller DH, Shibata EI, Shipsey IP, Pavlunin V, Cronin-Hennessy D, Kwon Y, Lyon AL, Thorndike EH. Study of charmless hadronic B meson decays to pseudoscalar-vector final states. PHYSICAL REVIEW LETTERS 2000; 85:2881-2885. [PMID: 11005959 DOI: 10.1103/physrevlett.85.2881] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/30/2000] [Indexed: 05/23/2023]
Abstract
We report results of searches for charmless hadronic B meson decays to pseudoscalar( pi(+/-), K+/-, pi(0), or K(0)(S))-vector( rho, K(*), or omega) final states. By using 9.7x10(6) BB pairs collected with the CLEO detector, we report the first observation of B(-)--->pi(-)rho(0), B(0)-->pi(+/-)rho(-/+), and B(-)-->pi(-)omega, which are expected to be dominated by hadronic b-->u transitions. The measured branching fractions are (10.4(+3.3)(-3.4)+/-2.1)x10(-6), (27.6(+8.4)(-7.4)+/-4.2)x10(-6), and (11.3(+3.3)(-2.9)+/-1. 4)x10(-6), respectively. Branching fraction upper limits are set for all of the other decay modes investigated.
Collapse
|
215
|
Overstreet J, Fuh V, Gould J, Howards S, Lieber M, Hellstrom W, Shapiro S, Carroll P, Corfman R, Petrou S, Lewis R, Toth P, Shown T, Roy J, Jarow J, Bonilla J, Jacobsen C, Wang D, Kaufman K. RE: CHRONIC TREATMENT WITH FINASTERIDE DAILY DOES NOT AFFECT SPERMATOGENESIS OR SEMEN PRODUCTION IN YOUNG MEN. J Urol 2000. [DOI: 10.1016/s0022-5347(05)67181-9] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
216
|
Van der Putten WH, Mortimer SR, Hedlund K, Van Dijk C, Brown VK, Lepä J, Rodriguez-Barrueco C, Roy J, Diaz Len TA, Gormsen D, Korthals GW, Lavorel S, Regina IS, Smilauer P. Plant species diversity as a driver of early succession in abandoned fields: a multi-site approach. Oecologia 2000; 124:91-99. [DOI: 10.1007/s004420050028] [Citation(s) in RCA: 152] [Impact Index Per Article: 6.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
217
|
Heinkelein M, Pietschmann T, Jármy G, Dressler M, Imrich H, Thurow J, Lindemann D, Bock M, Moebes A, Roy J, Herchenröder O, Rethwilm A. Efficient intracellular retrotransposition of an exogenous primate retrovirus genome. EMBO J 2000; 19:3436-45. [PMID: 10880456 PMCID: PMC313934 DOI: 10.1093/emboj/19.13.3436] [Citation(s) in RCA: 36] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/22/2022] Open
Abstract
The foamy virus (FV) subgroup of Retroviridae reverse transcribe their RNA (pre-)genome late in the replication cycle before leaving an infected cell. We studied whether a marker gene-transducing FV vector is able to shuttle to the nucleus and integrate into host cell genomic DNA. While a potential intracellular retrotransposition of vectors derived from other retroviruses was below the detection limit of our assay, we found that up to 5% of cells transfected with the FV vector were stably transduced, harboring 1 to approximately 10 vector integrants. Generation of the integrants depended on expression of functional capsid, reverse transcriptase and integrase proteins, and did not involve an extracellular step. PCR analysis of the U3 region of the 5' long terminal repeat and determination of proviral integration sites showed that a reverse transcription step had taken place to generate the integrants. Co-expression of a mutated envelope allowing particle egress and avoiding extracellular infection resulted in a significantly increased rescue of cells harboring integrants, suggesting that accumulation of proviruses via intracellular retrotransposition represents an integral part of the FV replication strategy.
Collapse
|
218
|
Roy J, Kazi M, Thyberg J, Hedin U. Fibronectin activates the p42/44 map kinase cascade and facilitates cell cycle entry of smooth muscle cells in primary culture. Atherosclerosis 2000. [DOI: 10.1016/s0021-9150(00)81085-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
|
219
|
Bonvicini G, Cinabro D, McGee S, Perera LP, Zhou GJ, Lipeles E, Pappas S, Schmidtler M, Shapiro A, Sun WM, Weinstein AJ, Jaffe DE, Masek G, Paar HP, Potter EM, Prell S, Sharma V, Asner DM, Eppich A, Hill TS, Morrison RJ, Nelson HN, Briere RA, Behrens BH, Ford WT, Gritsan A, Roy J, Smith JG, Alexander JP, Baker R, Bebek C, Berger BE, Berkelman K, Blanc F, Boisvert V, Cassel DG, Dickson M, Drell PS, Ecklund KM, Ehrlich R, Foland AD, Gaidarev P, Gibbons L, Gittelman B, Gray SW, Hartill DL, Heltsley BK, Hopman PI, Jones CD. Search for CP violation in B+/- --> J/psiK+/- and B+/- --> psi(2S)K+/- decays. PHYSICAL REVIEW LETTERS 2000; 84:5940-5944. [PMID: 10991094 DOI: 10.1103/physrevlett.84.5940] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/02/2000] [Indexed: 05/23/2023]
Abstract
We present a search for direct CP violation in B+/--->J/psiK+/- and B+/--->psi(2S)K+/- decays. In a sample of 9.7x10(6) B&Bmacr; meson pairs collected with the CLEO detector, we have fully reconstructed 534 B+/--->J/psiK+/- and 120 B+/--->psi(2S)K+/- decays with very low background. We have measured the CP-violating charge asymmetry to be [+1.8+/-4.3(stat)+/-0.4(syst)]% for B+/--->J/psiK+/- and [+2.0+/-9. 1(stat)+/-1.0(syst)]% for B+/--->psi(2S)K+/-.
Collapse
|
220
|
Abstract
The telomerase ribonucleoprotein has a phylogenetically divergent RNA subunit, which contains a short template for telomeric DNA synthesis. To understand how telomerase RNA participates in mechanistic aspects of telomere synthesis, we studied a conserved secondary structure adjacent to the template. Disruption of this structure caused DNA synthesis to proceed beyond the normal template boundary, resulting in altered telomere sequences, telomere shortening, and cellular growth defects. Compensatory mutations restored normal telomerase function. Thus, the RNA structure, rather than its sequence, specifies the template boundary. This study reveals a specific function for an RNA structure in the enzymatic action of telomerase.
Collapse
|
221
|
Taschereau R, Pouliot J, Roy J, Tremblay D. Seed misplacement and stabilizing needles in transperineal permanent prostate implants. Radiother Oncol 2000; 55:59-63. [PMID: 10788689 DOI: 10.1016/s0167-8140(00)00162-6] [Citation(s) in RCA: 71] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
BACKGROUND AND PURPOSE Seed misplacement occurring in transperineal permanent implants contributes to the degradation in dose coverage. It has been suggested that needles could be used to immobilize the prostate and help reduce misplacement. This study investigates the effects of parallel stabilizing needles on seed misplacement. MATERIALS AND METHODS A group of ten patients implanted with stabilizing needles was compared with a group of 20 patients implanted without stabilization. Measurements were performed on the displacement of individual seeds and needles. The needle measurements are: insertion angle, the ratio of post-implant over pre-implant lengths and the clustering tendency, a measure of relative misplacement among the seeds of the same needle. RESULTS No difference was observed in seed misplacement. No difference was observed in needle insertion angle, a measure which was expected to improve with the use of stabilizing needles. CONCLUSION None of the expected effects from the use of parallel stabilizing needles have been observed. This method of prostate contention appears to be without benefits. Seed misplacement is most pronounced along the insertion axis and is caused by friction between prostatic tissues and implantation needles. Reducing friction could be a promising alternative to prostate contention in trying to reduce misplacement.
Collapse
|
222
|
Roehrborn CG, McConnell J, Bonilla J, Rosenblatt S, Hudson PB, Malek GH, Schellhammer PF, Bruskewitz R, Matsumoto AM, Harrison LH, Fuselier HA, Walsh P, Roy J, Andriole G, Resnick M, Waldstreicher J. Serum prostate specific antigen is a strong predictor of future prostate growth in men with benign prostatic hyperplasia. PROSCAR long-term efficacy and safety study. J Urol 2000. [PMID: 10604304 DOI: 10.1016/s0022-5347(05)67962-1] [Citation(s) in RCA: 100] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
Abstract
PURPOSE We analyze patterns of prostate growth in men diagnosed with benign prostatic hyperplasia (BPH) and treated with placebo during 4 years, and determine which baseline parameters were the strongest predictors of growth. MATERIALS AND METHODS A total of 3,040 men were enrolled in the 4-year randomized, placebo controlled Proscar Long-Term Efficacy and Safety study. Of these men a subgroup of 10% underwent pelvic magnetic resonance imaging prostate volume measurement at baseline and yearly thereafter. Absolute and percent volume changes during 4 years were calculated in the 164 placebo treated men in the subgroup. The ability of age, baseline prostate volume and prostate specific antigen (PSA) to predict prostate growth in placebo treated patients was assessed by multiple linear regression analyses, receiver operator characteristics curves, and evaluations of growth stratified by tertiles of baseline serum PSA and decades of life. RESULTS In placebo treated patients a steady increase in mean plus or minus standard deviation prostate volume from year to year was noted (2.5+/-6.1, 4.9+/-6.8, 6.4+/-8.5 and 7.2+/-8.8 ml. at years 1, 2, 3 and 4, respectively). Mean volume changes at 4 years ranged from -9 to +30 ml. Mean percent change from baseline ranged from 12.5% to 16.6% for men 50 to 59 years old to those 70 to 79 years old. Baseline serum PSA was a strong predictor of growth with 7.4% to 22.0% change at 4 years from the lowest to highest PSA tertiles. Annualized growth rates from baseline were 0.7 ml. per year for PSA 0.2 to 1.3, 2.1 for PSA 1.4 to 3.2 and 3.3 for PSA 3.3 to 9.9 ng./ml. Multiple linear regression analysis showed that serum PSA was a stronger predictor of prostate growth than age or baseline prostate volume. All but 1 man with baseline serum PSA greater than 2.0 ng./ml. had prostate growth during 4 years, and 32.6% of men with serum PSA less than 2.0 exhibited a decrease in volume. CONCLUSIONS Serum PSA is a stronger predictor of growth of the prostate in placebo treated patients than age or baseline prostate volume. Since prostate volume is a risk factor for acute urinary retention and the need for BPH related surgery, the ability of PSA to predict prostate growth may be an important factor when considering individual treatment options for BPH. Such use of PSA represents a shift in paradigm away from focusing solely on symptoms of BPH toward a more comprehensive approach with consideration of predicting and preventing risk factors of BPH related outcomes.
Collapse
|
223
|
Roehrborn CG, McConnell J, Bonilla J, Rosenblatt S, Hudson PB, Malek GH, Schellhammer PF, Bruskewitz R, Matsumoto AM, Harrison LH, Fuselier HA, Walsh P, Roy J, Andriole G, Resnick M, Waldstreicher J. Serum prostate specific antigen is a strong predictor of future prostate growth in men with benign prostatic hyperplasia. PROSCAR long-term efficacy and safety study. J Urol 2000; 163:13-20. [PMID: 10604304] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/14/2023]
Abstract
PURPOSE We analyze patterns of prostate growth in men diagnosed with benign prostatic hyperplasia (BPH) and treated with placebo during 4 years, and determine which baseline parameters were the strongest predictors of growth. MATERIALS AND METHODS A total of 3,040 men were enrolled in the 4-year randomized, placebo controlled Proscar Long-Term Efficacy and Safety study. Of these men a subgroup of 10% underwent pelvic magnetic resonance imaging prostate volume measurement at baseline and yearly thereafter. Absolute and percent volume changes during 4 years were calculated in the 164 placebo treated men in the subgroup. The ability of age, baseline prostate volume and prostate specific antigen (PSA) to predict prostate growth in placebo treated patients was assessed by multiple linear regression analyses, receiver operator characteristics curves, and evaluations of growth stratified by tertiles of baseline serum PSA and decades of life. RESULTS In placebo treated patients a steady increase in mean plus or minus standard deviation prostate volume from year to year was noted (2.5+/-6.1, 4.9+/-6.8, 6.4+/-8.5 and 7.2+/-8.8 ml. at years 1, 2, 3 and 4, respectively). Mean volume changes at 4 years ranged from -9 to +30 ml. Mean percent change from baseline ranged from 12.5% to 16.6% for men 50 to 59 years old to those 70 to 79 years old. Baseline serum PSA was a strong predictor of growth with 7.4% to 22.0% change at 4 years from the lowest to highest PSA tertiles. Annualized growth rates from baseline were 0.7 ml. per year for PSA 0.2 to 1.3, 2.1 for PSA 1.4 to 3.2 and 3.3 for PSA 3.3 to 9.9 ng./ml. Multiple linear regression analysis showed that serum PSA was a stronger predictor of prostate growth than age or baseline prostate volume. All but 1 man with baseline serum PSA greater than 2.0 ng./ml. had prostate growth during 4 years, and 32.6% of men with serum PSA less than 2.0 exhibited a decrease in volume. CONCLUSIONS Serum PSA is a stronger predictor of growth of the prostate in placebo treated patients than age or baseline prostate volume. Since prostate volume is a risk factor for acute urinary retention and the need for BPH related surgery, the ability of PSA to predict prostate growth may be an important factor when considering individual treatment options for BPH. Such use of PSA represents a shift in paradigm away from focusing solely on symptoms of BPH toward a more comprehensive approach with consideration of predicting and preventing risk factors of BPH related outcomes.
Collapse
|
224
|
Rawal SB, Singh MV, Tyagi AK, Roy J, Dimri GP, Selvamurthy W. Effect of time exposure to high altitude on zinc and copper concentrations in human plasma. AVIATION, SPACE, AND ENVIRONMENTAL MEDICINE 1999; 70:1161-5. [PMID: 10596768] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/14/2023]
Abstract
BACKGROUND Research has focused mainly on the relationship of zinc and copper contents and physical stresses like running, cycling, etc. It has also been reported that other forms of stresses change the concentration of these trace elements in humans. However,there are no reports on the effects of high altitude induced hypoxic stress on the plasma levels of these metals. Since hypoxia is one of the important stresses, we considered it appropriate to observe the changes in the levels of zinc and copper concentrations and in certain related zinc and copper enzymes and hormones in the plasma of human volunteers on acute induction to high altitude. From these findings, we intended to ascertain whether supplementation of these trace elements would be required for optimal health under such conditions. HYPOTHESIS On acute induction to hypoxia, contents of these trace elements may change as the requirements of stressed organs and tissue may increase. Hence, further supplementation may be beneficial under hypoxic stress for better adaptability. METHOD Volunteers were divided into two groups: with and without zinc and copper salt supplementation. Blood samples were collected at sea level and on induction to acute hypoxia on days 3 and 10. Trace mineral contents and their related enzyme (alkaline phosphatase) and hormone (ceruloplasmin) levels were determined in plasma samples. RESULTS Plasma zinc contents were significantly reduced upon induction to high altitude in the non-supplemented group, but not in the zinc-supplemented group. Alkaline phosphatase activity increased significantly upon induction to the high altitude stress. The enzyme activity remained elevated up to day 10 of the stress. Plasma copper contents and ceruloplasmin activity did not change upon induction to high altitude. CONCLUSION Under hypoxic stress, circulating levels of zinc and alkaline phosphatase in plasma changed appreciably as plasma zinc was transported into the organs and tissues. However, circulating levels of copper and ceruloplasmin in plasma did not change, indicating no extra supplementation of copper is required under hypoxic stress.
Collapse
|
225
|
Das P, Xu J, Roy J, Chakrabarti N. Liquid crystal polymorphism in F-actin: Optical microscopic and rotatory dispersion studies. J Chem Phys 1999. [DOI: 10.1063/1.480157] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|
226
|
Overstreet JW, Fuh VL, Gould J, Howards SS, Lieber MM, Hellstrom W, Shapiro S, Carroll P, Corfman RS, Petrou S, Lewis R, Toth P, Shown T, Roy J, Jarow JP, Bonilla J, Jacobsen CA, Wang DZ, Kaufman KD. Chronic treatment with finasteride daily does not affect spermatogenesis or semen production in young men. J Urol 1999; 162:1295-300. [PMID: 10492183] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/14/2023]
Abstract
PURPOSE Finasteride, an oral type 2, 5alpha-reductase inhibitor, is used in 1 mg. daily doses for the treatment of male pattern hair loss. A dose of 5 mg. finasteride daily reduces ejaculate volume by approximately 25%, and reduces prostate volume by approximately 20% and serum prostate specific antigen (PSA) by approximately 50% in men with benign prostatic hyperplasia. To our knowledge no data exist on the effect of 1 mg. finasteride daily on ejaculate volume or other semen parameters, or on the prostate in young men. Therefore, we studied the potential effect and reversibility of effect of 1 mg. finasteride daily on spermatogenesis, semen production, the prostate and serum PSA in young men. MATERIALS AND METHODS In this double-blind, placebo controlled multicenter study 181 men 19 to 41 years old were randomized to receive 1 mg. finasteride or placebo for 48 weeks followed by a 60-week off-drug period. Of the 181 men 79 were included in a subset for the collection and analysis of sequential semen samples. RESULTS There were no significant effects of 1 mg. finasteride on sperm concentration, total sperm per ejaculate, sperm motility or morphology. Ejaculate volume in subjects on finasteride decreased 0.3 ml. (-11%) compared to a decrease of 0.2 ml. (-8%) for placebo, with a median between treatment group difference of -0.03 ml. (1%, 90% confidence interval -10.4 to 13.1, p = 0.915). There were significant but small decreases in prostate volume (-2.6%) and serum PSA (-0.2 ng./ml.) in the finasteride group, which reversed on discontinuation of the drug. CONCLUSIONS Treatment with 1 mg. finasteride daily for 48 weeks did not affect spermatogenesis or semen production in young men. The effects of 1 mg. finasteride daily on prostate volume and serum PSA in young men without benign prostatic hyperplasia were small and reversible on discontinuation of the drug.
Collapse
|
227
|
Taschereau R, Roy J, Pouliot J. Monte Carlo simulations of prostate implants to improve dosimetry and compare planning methods. Med Phys 1999; 26:1952-9. [PMID: 10505885 DOI: 10.1118/1.598700] [Citation(s) in RCA: 31] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
Abstract
The objective of this study is to use Monte Carlo simulations to assess the sensitivity of implant planning methods to seed misplacement. A model of seed misplacement is first developed. It is based upon data gathered after a study on source migration performed on 30 patients treated with I-125 transperineal implants. It consists of applying elementary transformations to every needle in a loading plan to produce a distorted implant mimicking the effect of migration. After being validated, the model has been used to tune the inverse planning system in use at our institution. The new planning system is now used clinically and actual results are compared with those predicted by simulations. Simulations were also used to compare our planning method with others. The new planning system increased the average postimplant dose-volume histogram DVH(160) from 82% to 93%, which is the value predicted by the simulations. This improvement is due to an increased dose margin providing coverage even in the presence of migration. At the same time, the dose to the urethra remained at 267 Gy because of a special protection feature included in the planning system. Some other implant planning methods are not as robust [average DVH(160) ranging from 76% to 85%] and deliver a higher dose to the urethra (close to 400 Gy). To conclude, a simple model of source migration can provide realistic feedback about sensitivity to migration of planning methods. It allowed a significant clinical improvement at our institution. The improved inverse planning system provided better coverage with fewer seeds (but equal total activity) than a manual method. Hence, a properly tuned inverse planning system has the potential to deliver the less sensitive plans. The model also helped demonstrate that planning methods are not equally robust to migration and that they should not be evaluated solely by the plans they produce, but also by their clinical (or simulated) results.
Collapse
|
228
|
Hedin U, Roy J, Tran PK, Lundmark K, Rahman A. Control of smooth muscle cell proliferation--the role of the basement membrane. Thromb Haemost 1999; 82 Suppl 1:23-6. [PMID: 10695481] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/15/2023]
Abstract
In atherogenesis and in response to vessel injury, arterial smooth muscle cells (SMCs) are activated from a quiescent, differentiated state into an actively proliferating and synthetic phenotype which migrate into the intima where the cells participate in the formation of a fibrous plaque or intimal hyperplasia. The mechanisms involved in the control of SMC function are not clear and no preventive therapy against SMC activation is available. Interactions between SMCs and the extracellular matrix have been shown to influence SMC structure and function through integrin-mediated signaling processes. The SMC basement membrane is a specific form of extracellular matrix which seems to be crucial for the maintenance of SMC quiescence and the disruption of these interactions is part of cellular activation after atherogenic or traumatic stimuli. This concept of "negative growth control" may constitute a future target for the development of new strategies in the prevention of SMC activation in atherogenesis and restenosis formation.
Collapse
|
229
|
Brochu S, Rioux-Massé B, Roy J, Roy DC, Perreault C. Massive activation-induced cell death of alloreactive T cells with apoptosis of bystander postthymic T cells prevents immune reconstitution in mice with graft-versus-host disease. Blood 1999; 94:390-400. [PMID: 10397705] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/13/2023] Open
Abstract
After hematopoietic stem cell transplantation, the persistence and expansion of grafted mature postthymic T cells allow both transfer of donor immunologic memory and generation of a diverse T repertoire. This thymic-independent process, which is particularly important in humans, because most transplant recipients present severe thymus atrophy, is impaired by graft-versus-host disease (GVHD). The goal of this study was to decipher how GVHD influences the fate of grafted postthymic T cells. Two major findings emerged. First, we found that, after a brisk proliferation phase, alloreactive antihost T cells underwent a massive activation-induced cell death (AICD). For both CD4(+) and CD8(+) T cells, the Fas pathway was found to play a major role in this AICD: alloreactive T cells upregulated Fas and FasL, and AICD of antihost T cells was much decreased in the case of lpr (Fas-deficient) donors. Second, whereas non-host-reactive donor T cells neither upregulated Fas nor suffered apoptosis when transplanted alone, they showed increased membrane Fas expression and apoptosis when coinjected with host-reactive T cells. We conclude that GVHD-associated AICD of antihost T cells coupled with bystander lysis of grafted non-host-reactive T cells abrogate immune reconstitution by donor-derived postthymic T lymphocytes. Furthermore, we speculate that massive lymphoid apoptosis observed in the acute phase of GVHD might be responsible for the occurrence of autoimmunity in the chronic phase of GVHD.
Collapse
|
230
|
LeBlanc R, Roy J, Demers C, Vu L, Cantin G. A prospective study of G-CSF effects on hemostasis in allogeneic blood stem cell donors. Bone Marrow Transplant 1999; 23:991-6. [PMID: 10373063 DOI: 10.1038/sj.bmt.1701756] [Citation(s) in RCA: 60] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/19/2022]
Abstract
Granulocyte colony-stimulating factor (G-CSF) is used in healthy donors of peripheral blood stem cells (PBSC) for allogeneic transplantation. However, some data have recently suggested that G-CSF may induce a hypercoagulable state, prompting us to study prospectively 22 PBSC donors before and after G-CSF 5 microg/kg twice daily. We sought evidence for changes in the following parameters: platelet count, von Willebrand factor antigen (vWF:Ag) and activity (vWF activity), beta-thromboglobulin (beta-TG), platelet factor 4 (PF-4), platelet activation markers (GMP-140 and PAC-1), activated partial thromboplastin time (aPTT), prothrombin time (PT), coagulant factor VIII (FVIII:C), thrombin-antithrombin complex (TAT), prothrombin fragment 1+2 (F1+2), thrombomodulin (TM) and tissue plasminogen activator antigen (tPA:Ag) prior to G-CSF and immediately before leukapheresis. ADP-induced platelet aggregation studies were also performed. G-CSF administration produced only mild discomfort. We found a significant increase in vWF:Ag (from 0.99 +/- 0.32 U/ml to 1.83 +/- 0.69 U/ml; P < 0.001), in vWF activity (from 1.04 +/- 0.34 U/ml to 1.78 +/- 0.50 U/ml; P < 0.001) and in FVIII:C (from 1.12 +/- 0.37 U/ml to 1.73 +/- 0.57 U/ml; P < 0.001) after G-CSF. Of note, four donors with low baseline vWF had a two- to three-fold increase after receiving G-CSF. G-CSF had no impact on the platelet count, beta-TG, PF-4, GMP-140 or PAC-1. The final% of platelet aggregation decreased from 73 +/- 22% to 37 +/- 26% after G-CSF (P < 0.001). We found a significant decrease in aPTT after G-CSF (29.9 +/- 3.1 s to 28.3 +/- 3.3 s; P = 0.004), but the PT was unaffected. In addition, we also observed a significant increase in TAT, F1+2 and TM, but not in tPA:Ag. Our data suggest that G-CSF may possibly induce a hypercoagulable state by increasing levels of FVIII:C and thrombin generation. In contrast to this information, we found reduced platelet aggregation after G-CSF administration. The clinical implications of these findings remain unclear and larger studies are definitely required.
Collapse
|
231
|
Roy J, Ryckman C, Bernier V, Whittom R, Delage R. The authors reply. Leukemia 1999. [DOI: 10.1038/sj.leu.2401346] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
|
232
|
Peavey L, Roy J, Baron-Cyr M, Dumas W, Etkind P. Vaccinating high school students against hepatitis B: a school/STD clinic collaboration. Am J Public Health 1999; 89:412-3. [PMID: 10076496 PMCID: PMC1508594 DOI: 10.2105/ajph.89.3.412] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
233
|
Bruening W, Roy J, Giasson B, Figlewicz DA, Mushynski WE, Durham HD. Up-regulation of protein chaperones preserves viability of cells expressing toxic Cu/Zn-superoxide dismutase mutants associated with amyotrophic lateral sclerosis. J Neurochem 1999; 72:693-9. [PMID: 9930742 DOI: 10.1046/j.1471-4159.1999.0720693.x] [Citation(s) in RCA: 208] [Impact Index Per Article: 8.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
Mutations in the Cu/Zn-superoxide dismutase (SOD-1) gene underlie some familial cases of amyotrophic lateral sclerosis, a neurodegenerative disorder characterized by loss of cortical, brainstem, and spinal motor neurons. We present evidence that SOD-1 mutants alter the activity of molecular chaperones that aid in proper protein folding and targeting of abnormal proteins for degradation. In a cultured cell line (NIH 3T3), resistance to mutant SOD-1 toxicity correlated with increased overall chaperoning activity (measured by the ability of cytosolic extracts to prevent heat denaturation of catalase) as well as with up-regulation of individual chaperones/stress proteins. In transgenic mice expressing human SOD-1 with the G93A mutation, chaperoning activity was decreased in lumbar spinal cord but increased or unchanged in clinically unaffected tissues. Increasing the level of the stress-inducible chaperone 70-kDa heat shock protein by gene transfer reduced formation of mutant SOD-containing proteinaceous aggregates in cultured primary motor neurons expressing G93A SOD-1 and prolonged their survival. We propose that insufficiency of molecular chaperones may be directly involved in loss of motor neurons in this disease.
Collapse
|
234
|
Albert M, Fortin A, Allard J, Roy J, Vigneault E. 2176 The effect of treatment delay on head and neck carcinomas treated with radiotherapy. Int J Radiat Oncol Biol Phys 1999. [DOI: 10.1016/s0360-3016(99)90445-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
235
|
Tschereau R, Roy J, Pouliot J. 2283 A comparison of planning methods in permanent prostate implants. Int J Radiat Oncol Biol Phys 1999. [DOI: 10.1016/s0360-3016(99)90551-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
236
|
Fortin A, Allard J, Albert M, Roy J, Vigneault E, Tremblay D. 1040 Treatment results for patients treated with cobalt and 6 MV in head and neck cancers. Int J Radiat Oncol Biol Phys 1999. [DOI: 10.1016/s0360-3016(99)90266-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
237
|
Roy J, Minotti S, Dong L, Figlewicz DA, Durham HD. Glutamate potentiates the toxicity of mutant Cu/Zn-superoxide dismutase in motor neurons by postsynaptic calcium-dependent mechanisms. J Neurosci 1998; 18:9673-84. [PMID: 9822728 PMCID: PMC6793286] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/24/1998] [Revised: 09/15/1998] [Accepted: 09/16/1998] [Indexed: 02/09/2023] Open
Abstract
Mutations in the Cu/Zn-superoxide dismutase (SOD-1) gene are responsible for a subset of familial cases of amyotrophic lateral sclerosis. Using a primary culture model, we have demonstrated that normally nontoxic glutamatergic input, particularly via calcium-permeable AMPA/kainate receptors, is a major factor in the vulnerability of motor neurons to the toxicity of SOD-1 mutants. Wild-type and mutant (G41R, G93A, or N139K) human SOD-1 were expressed in motor neurons of dissociated cultures of murine spinal cord by intranuclear microinjection of plasmid expression vector. Both a general antagonist of AMPA/kainate receptors (CNQX) and a specific antagonist of calcium-permeable AMPA receptors (joro spider toxin) reduced formation of SOD-1 proteinaceous aggregates and prevented death of motor neurons expressing SOD-1 mutants. Partial protection was obtained by treatment with nifedipine, implicating Ca2+ entry through voltage-gated calcium channels as well as glutamate receptors in potentiating the toxicity of mutant SOD-1 in motor neurons. Dramatic neuroprotection was obtained by coexpressing the calcium-binding protein calbindin-D28k but not by increasing intracellular glutathione levels or treatment with the free radical spin trap agent, N-tert-butyl-alpha-phenylnitrone. Thus, generalized oxidative stress could have contributed in only a minor way to death of motor neurons expressing the mutant SOD-1. These studies demonstrated that the toxicity of these mutants is calcium-dependent and provide direct evidence that calcium entry during neurotransmission, coupled with deficiency of cytosolic calcium-binding proteins, is a major factor in the preferential vulnerability of motor neurons to disease.
Collapse
|
238
|
Delage R, Roy J, Jacques L, Darveau A. All patients with persistent polyclonal B cell lymphocytosis present Bcl-2/Ig gene rearrangements. Leuk Lymphoma 1998; 31:567-74. [PMID: 9922047 DOI: 10.3109/10428199809057616] [Citation(s) in RCA: 29] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
Abstract
The bcl-2 gene belongs to a class of oncogenes involved in the inhibition of apoptosis. Most follicular lymphomas are associated with the t(14;18) translocation that juxtaposes the bcl-2 gene located on chromosome 18 to the immunoglobulin gene locus located on chromosome 14. Consequently, the bcl-2 gene is overly expressed and leads to an accumulation of mature clonal B cells. Prolonged survival of the B cell clone appears to be the early event in tumorigenesis, creating an increased risk of cumulative mutations. Interestingly, bcl-2/Ig gene rearrangements may be identified in nearly 50% of normal individuals but the outcome of normal individuals carrying high levels of t(14;18) is not well defined. Persistent polyclonal B cell lymphocytosis (PPBL) is a unique polyclonal lymphoproliferative disorder mostly restricted to women. We have recently demonstrated that PPBL is also associated with multiple bcl-2/Ig gene rearrangements. In this report, we have extended our analysis to additional patients and demonstrated that all patients presented multiple detectable t(14;18) translocated clones. In addition, Bcl-2 protein expression was increased. Our findings, along with the clinical features of PPBL, make this disorder an exceptional model for the study of B-cell homeostasis.
Collapse
MESH Headings
- Adult
- Antigens, CD19/analysis
- B-Lymphocytes/chemistry
- B-Lymphocytes/pathology
- Biomarkers
- Chromosomes, Human, Pair 14/genetics
- Chromosomes, Human, Pair 14/ultrastructure
- Chromosomes, Human, Pair 18/genetics
- Chromosomes, Human, Pair 18/ultrastructure
- Female
- Follow-Up Studies
- Gene Expression
- Genes, Immunoglobulin
- Genes, bcl-2
- HLA-DR7 Antigen/analysis
- Humans
- Lymphocytosis/genetics
- Lymphocytosis/pathology
- Lymphoproliferative Disorders/genetics
- Lymphoproliferative Disorders/pathology
- Male
- Middle Aged
- Polymerase Chain Reaction
- Proto-Oncogene Proteins c-bcl-2/biosynthesis
- Translocation, Genetic
Collapse
|
239
|
Roy J, Fulton TB, Blackburn EH. Specific telomerase RNA residues distant from the template are essential for telomerase function. Genes Dev 1998; 12:3286-300. [PMID: 9784502 PMCID: PMC317211 DOI: 10.1101/gad.12.20.3286] [Citation(s) in RCA: 63] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/26/1998] [Accepted: 08/26/1998] [Indexed: 11/24/2022]
Abstract
The reverse transcriptase telomerase is a ribonucleoprotein complex that adds telomeric repeats to chromosome ends, using a sequence within its endogenous RNA component as a template. Although templating domains of telomerase RNA have been studied in detail, little is known about the roles of the remaining residues, particularly in yeast. We examined the functions of nontemplate telomerase residues in the telomerase RNA of budding yeast Kluyveromyces lactis. Although approximately half of the RNA residues were dispensable for function, four specific regions were essential for telomerase action in vivo. We analyzed the effects of mutating these regions on in vivo function, in vitro telomerase activity, and telomerase RNP assembly. Deletion of two regions resulted in synthesis of stable RNAs that appeared unable to assemble into a stable RNP. Mutating a region near the 5' end of the RNA allowed RNP assembly but abolished enzymatic activity. Mutations in another specific small region of the RNA led to an inactive telomerase RNP with an altered RNA conformation.
Collapse
|
240
|
Sévigny J, Grondin G, Gendron FP, Roy J, Beaudoin AR. Demonstration and immunolocalization of ATP diphosphohydrolase in the pig digestive system. THE AMERICAN JOURNAL OF PHYSIOLOGY 1998; 275:G473-82. [PMID: 9724258 DOI: 10.1152/ajpgi.1998.275.3.g473] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/03/2023]
Abstract
Two isoforms of ATP diphosphohydrolase (ATPDase; EC 3.6.1.5) have been previously characterized, purified, and identified. This enzyme is an ectonucleotidase that catalyzes the sequential release of gamma- and beta-phosphate groups of triphospho- and diphosphonucleosides. One of its putative roles is to modulate the extracellular concentrations of purines in different physiological systems. The purpose of this study was to define, identify, and localize these two isoforms of ATPDase in the pig digestive system. ATPDase activity was measured in pig stomach, duodenum, pancreas, and parotid gland. Enzyme assays, electrophoretograms, and Western blots with a polyclonal antibody that recognizes both isoforms demonstrate the presence of ATPDase in these organs. Immunolocalization showed intense reactions with gastric glands (parietal and chief cells), intestine (columnar epithelial cells), parotid gland, and pancreas. Smooth muscle cells all along the digestive tract were also highly reactive. Considering the variety of purinoceptors associated with the digestive system, the ATPDase is strategically positioned to modulate purine-mediated actions such as electrolyte secretion, glandular secretion, smooth muscle contraction, and blood flow.
Collapse
|
241
|
Doyon J, Laforce R, Bouchard G, Gaudreau D, Roy J, Poirier M, Bédard PJ, Bédard F, Bouchard JP. Role of the striatum, cerebellum and frontal lobes in the automatization of a repeated visuomotor sequence of movements. Neuropsychologia 1998; 36:625-41. [PMID: 9723934 DOI: 10.1016/s0028-3932(97)00168-1] [Citation(s) in RCA: 125] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/08/2023]
Abstract
Recently, Doyon et al. [20] demonstrated that lesions to both the striatum and to the cerebellum in humans produce a similar deficit in the learning of a repeated visuomotor sequence, which occurs late in the acquisition process. We now report the results of two experiments that were designed to examine whether this impairment was due to a lack of automatization of the repeating sequence of finger movements by using a dual-task paradigm and by testing for long-term retention of this skill. In Experiment 1, the performance of groups of patients with Parkinson's disease, or with damage to the cerebellum or to the frontal lobes, was compared to that of matched control subjects on the Repeated Sequence Test (primary task) and the Brooks' Matrices Test (secondary task). These two tests were administered concomitantly in both early and late learning phases of the visuomotor sequence. Overall, the groups did not differ in their ability to execute the primary task. By contrast, in accordance with the predictions, patients in Stages 2-3 of Parkinson's disease or with a cerebellar lesion failed to reveal the expected increase in performance on the secondary task seen with learning, suggesting that the latter groups of patients did not have access to the same level of residual cognitive resources to complete the matrices compared to controls. In Experiment 2, the same groups of patients and control subjects were retested again 10-18 months later. They were given four blocks of 100 trials each of the repeating sequence task, followed by a questionnaire and a self-generation task that measured their declarative knowledge of that sequence. The results revealed a long-term retention impairment only in patients who changed from Stage I to Stage II of the disease (suggesting further striatal degeneration) during the one-year interval, or who had a cerebellar lesion. By contrast, performance of the three clinical groups did not differ from controls on declarative memory tests. These findings suggest that both the striatum and the cerebellum participate to the automatization process during the late (slow) learning stage of a sequence of finger movements and that these structures also play a role in the neuronal mechanism subserving long-term retention of such a motor sequence behavior.
Collapse
|
242
|
Roy J, Ryckman C, Bernier V, Whittom R, Delage R. Large cell lymphoma complicating persistent polyclonal B cell lymphocytosis. Leukemia 1998; 12:1026-30. [PMID: 9665185 DOI: 10.1038/sj.leu.2401040] [Citation(s) in RCA: 17] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/08/2023]
Abstract
Persistent polyclonal B cell lymphocytosis (PPBL) is a rare lymphoproliferative disorder of unclear natural history and its potential for B cell malignancy remains unknown. We describe the case of a 39-year-old female who presented with stage IV-B large cell lymphoma 19 years after an initial diagnosis of PPBL; her disease was rapidly fatal despite intensive chemotherapy and blood stem cell transplantation. Because we had recently identified multiple bcl-2/Ig gene rearrangements in blood mononuclear cells of patients with PPBL, we sought evidence of this oncogene in this particular patient: bcl-2/Ig gene rearrangements were found in blood mononuclear cells but not in lymphoma cells. Owing to the possible role of Epstein-Barr virus (EBV) in the pathogenesis of PPBL, we also hypothesized our patient might have an EBV-related lymphoproliferative disorder. Despite serologies consistent with past exposure to this virus, it was not found in lymphoma cells using a sensitive polymerase chain reaction technique. We conclude that non-Hodgkin's lymphoma may occur during the course of PPBL. However, longer follow-up in more patients will be needed in order to better clarity the risk of hematologic malignancy in patients with PPBL.
Collapse
|
243
|
Watanabe Y, Roy J, Harrington PJ, Anderson LL. Experimental and Monte Carlo dosimetry of the Henschke applicator for high dose-rate 192Ir remote afterloading. Med Phys 1998; 25:736-45. [PMID: 9608485 DOI: 10.1118/1.598255] [Citation(s) in RCA: 15] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
Abstract
We have performed extensive computational and experimental dosimetry of the Henschke applicator with respect to high dose-rate 192Ir brachytherapy using a GAMMAMED remote afterloader. Our goal was to generate clinically useful two- and three-dimensional look-up tables. Dose measurements of the Henschke applicator involved using TLD chips placed in a polystyrene phantom. Monte Carlo simulations were performed using the MCNP code. The computational models included the detailed geometry of 192Ir source, tandem tube, and shielded ovoid. The measured dose rates were corrected for the dependence of TLD sensitivity on the distance of measurement points from the source. Transit dose delivered during source extension to and retraction from a given dwell position was estimated by Monte Carlo simulations, and a correction was applied to the experimental values. For the applicator tandem, the ratio of dose rates obtained by MCNP to those measured by TLD chips ranges from 0.92 to 1.10 with an average of 0.98 and a standard deviation of 0.02. The measured and calculated dose rates at 1 cm on the transverse axis are 1.10 cGy U-1 h-1. For the shielded ovoid, the ratio ranges from 0.88 to 1.16 with an average of 1.00 and a standard deviation of 0.07. Causes of the discrepancy between the Monte Carlo and TLD results were identified. We found that the combined uncertainty of measured dose rates due to these causes is 5.6% for the applicator tandem and 8.4% for the shielded ovoid. Therefore, the results of the Monte Carlo simulation are considered to have been validated by the measurements within the uncertainty involved in the calculation and measurements.
Collapse
|
244
|
Oesterling JE, Roy J, Agha A, Shown T, Krarup T, Johansen T, Lagerkvist M, Gormley G, Bach M, Waldstreicher J. Biologic variability of prostate-specific antigen and its usefulness as a marker for prostate cancer: effects of finasteride. Finasteride PSA Study Group. Urology 1998; 51:58-63. [PMID: 9586598 DOI: 10.1016/s0090-4295(98)00059-4] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
Abstract
OBJECTIVES The effects of finasteride on prostate-specific antigen (PSA) variability and usefulness in prostate cancer detection were examined. METHODS Percent change and crossover of PSA levels between the low (1.0 to 3.9 ng/mL) and high (4.0 to 10.0 ng/mL) ranges were evaluated in 72 men with benign prostatic hyperplasia (BPH) and 77 men with both BPH and prostate cancer (PCa) treated with finasteride or placebo for 6 months. Patients with PCa were studied as a model for evaluating the effects on PSA levels in patients with BPH and latent PCa. As recommended on the product label, PSA levels for finasteride-treated patients were doubled for interpretation. RESULTS In patients with BPH, most placebo- and finasteride-treated patients with low PSA levels at baseline had subsequent PSA levels below 4.0 ng/mL throughout the study. Among patients with high baseline PSA levels, only 1 of 17 finasteride-treated patients, compared with 8 of 13 placebo-treated patients, crossed into the low range. In the BPH/PCa study, most placebo-treated patients maintained PSA levels in the same range (15 of 19 less than 4.0 ng/mL; 14 of 16 greater than 4.0 ng/mL). Almost one third of finasteride-treated patients with low PSA levels at baseline crossed into the high range (8 of 22), whereas most patients with high PSA levels at baseline were not masked with treatment, with PSA levels remaining high (12 of 15). CONCLUSIONS PSA levels cross between the low and high PSA ranges in both finasteride- and placebo-treated patients with BPH and those with both BPH and PCa. Doubling the PSA levels in finasteride-treated patients allows appropriate interpretation of PSA values and does not mask the detection of PCa.
Collapse
|
245
|
Hedin U, Thyberg J, Roy J, Dumitrescu A, Tran PK. Role of tyrosine kinases in extracellular matrix-mediated modulation of arterial smooth muscle cell phenotype. Arterioscler Thromb Vasc Biol 1997; 17:1977-84. [PMID: 9351362 DOI: 10.1161/01.atv.17.10.1977] [Citation(s) in RCA: 27] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
Abstract
Fibronectin (FN) promotes the modulation of freshly isolated arterial smooth muscle cells (SMCs) from a contractile to a synthetic phenotype by interacting with integrins on the cell surface. This process is characterized by a structural and functional transformation of the cells, including a reorganization of the cytoskeleton, the formation of a large secretory apparatus, and the acquisition of proliferative capacity. In this study we have investigated the role of integrin signaling through tyrosine kinases in the structural changes that occur in SMCs during primary culture on FN. A gradual increase in phosphotyrosine staining in focal adhesions and a concomitant increase in tyrosine phosphorylation of proteins including focal adhesion kinase were observed. In contrast, cells seeded on laminin formed few focal adhesions, and tyrosine phosphorylation of proteins was less than in cells cultured on FN. Treatment of cells cultured on FN with the tyrosine kinase inhibitor genistein strongly suppressed focal adhesion formation, cell spreading, and cytoskeletal reorganization. In addition, electron microscopic analysis demonstrated that the phenotypic modulation was slowed down. These results indicate that the ability of extracellular matrix components to promote a change in the phenotypic properties of SMCs depends on the assembly of focal adhesions with associated tyrosine kinase activity.
Collapse
|
246
|
Chowdhury A, Chatterjee BK, Dutta P, Roy J, Chowdhury T, Das K, Goenka MK. Pancreas divisum with chronic calcific pancreatitis: cause or coincidence. TROPICAL GASTROENTEROLOGY : OFFICIAL JOURNAL OF THE DIGESTIVE DISEASES FOUNDATION 1997; 18:172-3. [PMID: 9612101] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
|
247
|
Oesterling JE, Roy J, Agha A, Shown T, Krarup T, Johansen T, Lagerkvist M, Gormley G, Bach M, Waldstreicher J. Biologic variability of prostate-specific antigen and its usefulness as a marker for prostate cancer: effects of finasteride. The Finasteride PSA Study Group. Urology 1997; 50:13-8. [PMID: 9218012 DOI: 10.1016/s0090-4295(97)00156-8] [Citation(s) in RCA: 34] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/04/2023]
Abstract
OBJECTIVES The effects of finasteride on prostate-specific antigen (PSA) variability and usefulness in prostate cancer detection were examined. METHODS Percent change and crossover of PSA levels between the low (1.0 to 3.9 ng/mL) and high (4.0 to 10.0 ng/mL) ranges were evaluated in 72 men with benign prostatic hyperplasia (BPH) and 77 men with both BPH and prostate cancer (PCa) treated with finasteride or placebo for 6 months. Patients with PCa were studied as a model for evaluating the effects on PSA levels in patients with BPH and latent PCa. As recommended on the product label, PSA levels for finasteride-treated patients were doubled for interpretation. RESULTS In patients with BPH, most placebo- and finasteride-treated patients with low PSA levels at baseline had subsequent PSA levels below 4.0 ng/mL throughout the study. Among patients with high baseline PSA levels, only 1 of 17 finasteride-treated patients compared with 8 of 13 placebo-treated patients crossed into the low range. In the BPH/PCa study, most placebo-treated patients maintained PSA levels in the same range (15 of 19 less than 4.0 ng/mL; 14 of 16 greater than 4.0 ng/mL). Almost one third of finasteride-treated patients with low PSA levels at baseline crossed into the high range (8 of 22), whereas most patients with high PSA levels at baseline were not masked with treatment, with PSA levels remaining high (12 of 15). CONCLUSIONS PSA levels cross between the low and high PSA ranges in both finasteride- and placebo-treated patients with BPH and those with both BPH and PCa. Doubling the PSA levels in finasteride-treated patients allows appropriate interpretation of PSA values and does not mask the detection of PCa.
Collapse
|
248
|
Thyberg J, Roy J, Tran PK, Blomgren K, Dumitrescu A, Hedin U. Expression of caveolae on the surface of rat arterial smooth muscle cells is dependent on the phenotypic state of the cells. J Transl Med 1997; 77:93-101. [PMID: 9251682] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/05/2023] Open
Abstract
Both after vascular injury and when established in vitro, arterial smooth muscle cells pass through a characteristic change in phenotype. This process includes a prominent structural reorganization with partial loss of myofilaments and formation of a large endoplasmic reticulum and Golgi complex. As a result, the cells lose their contractility and become able instead to divide and to secrete extracellular matrix components. In the present study, the expression of plasma membrane caveolae in rat arterial smooth muscle cells was studied in primary culture and during the formation of neointimal thickenings after balloon injury. Electron microscopic analysis revealed that the number of caveolae (identified as flask-shaped invaginations of the plasma membrane) was reduced when the cells converted from a contractile to a synthetic phenotype (as defined morphologically) and then increased again when they readopted a more differentiated state. However, immunoblotting analysis did not show any changes in the cellular content of caveolin (a major protein component of caveolae) during the 1st week in culture. At the same time, immunocytochemical staining demonstrated a shift in the localization of caveolin from small spot-like structures dispersed over the cell surface to vesicular structures in the perinuclear cytoplasm. These findings indicate that the transition of smooth muscle cells from a contractile to a synthetic phenotype involves a marked decline in the number of plasma membrane caveolae. In parallel, caveolin is internalized and redistributed to Golgi-associated vesicles in the perinuclear cytoplasm. In context of the rapidly increasing awareness of the importance of caveolae both in signal transduction and intracellular cholesterol transport, it seems likely that the variations in the number of caveolae may be significant for the functional differences between smooth muscle cells in different phenotypes.
Collapse
|
249
|
Coan TE, Fadeyev V, Korolkov I, Maravin Y, Narsky I, Shelkov V, Staeck J, Stroynowski R, Volobouev I, Ye J, Artuso M, Efimov A, Frasconi F, Gao M, Goldberg M, He D, Kopp S, Moneti GC, Mountain R, Schuh S, Skwarnicki T, Stone S, Viehhauser G, Xing X, Bartelt J, Csorna SE, Jain V, Marka S, Freyberger A, Godang R, Kinoshita K, Lai IC, Pomianowski P, Schrenk S, Bonvicini G, Cinabro D, Greene R, Perera LP, Zhou GJ, Barish B, Chadha M, Chan S, Eigen G, Miller JS, O’Grady C, Schmidtler M, Urheim J, Weinstein AJ, Würthwein F, Asner DM, Bliss DW, Brower WS, Masek G, Paar HP, Sharma V, Gronberg J, Hill TS, Kutschke R, Lange DJ, Menary S, Morrison RJ, Nelson HN, Nelson TK, Qiao C, Richman JD, Roberts D, Ryd A, Witherell MS, Balest R, Behrens BH, Cho K, Ford WT, Park H, Rankin P, Roy J, Smith JG, Alexander JP, Bebek C, Berger BE, Berkelman K, Bloom K, Cassel DG, Cho HA, Coffman DM, Crowcroft DS, Dickson M, Drell PS, Ecklund KM, Ehrlich R, Elia R, Foland AD, Gaidarev P, Galik RS, Gittelman B, Gray SW, Hartill DL, Heltsley BK, Hopman PI, Kandaswamy J, Katayama N, Kim PC, Kreinick DL, Lee T, Liu Y, Ludwig GS, Masui J, Mevissen J, Mistry NB, Ng CR, Nordberg E, Ogg M, Patterson JR, Peterson D, Riley D, Soffer A, Ward C, Athanas M, Avery P, Jones CD, Lohner M, Prescott C, Yelton J, Zheng J, Brandenburg G, Briere RA, Gao YS, Kim DYJ, Wilson R, Yamamoto H, Browder TE, Li F, Li Y, Rodriguez JL, Bergfeld T, Eisenstein BI, Ernst J, Gladding GE, Gollin GD, Hans RM, Johnson E, Karliner I, Marsh MA, Palmer M, Selen M, Thaler JJ, Edwards KW, Bellerive A, Janicek R, MacFarlane DB, McLean KW, Patel PM, Sadoff AJ, Ammar R, Baringer P, Bean A, Besson D, Coppage D, Darling C, Davis R, Hancock N, Kotov S, Kravchenko I, Kwak N, Anderson S, Kubota Y, Lattery M, Lee SJ, O’Neill JJ, Patton S, Poling R, Riehle T, Savinov V, Smith A, Alam MS, Athar SB, Ling Z, Mahmood AH, Severini H, Timm S, Wappler F, Anastassov A, Blinov S, Duboscq JE, Fisher KD, Fujino D, Fulton R, Gan KK, Hart T, Honscheid K, Kagan H, Kass R, Lee J, Spencer MB, Sung M, Undrus A, Wanke R, Wolf A, Zoeller MM, Nemati B, Richichi SJ, Ross WR, Skubic P, Wood M, Bishai M, Fast J, Gerndt E, Hinson JW, Menon N, Miller DH, Shibata EI, Shipsey IPJ, Yurko M, Gibbons L, Johnson SD, Kwon Y, Roberts S, Thorndike EH, Jessop CP, Lingel K, Marsiske H, Perl ML, Schaffner SF, Ugolini D, Wang R, Zhou X. ντhelicity fromh±energy correlations. Int J Clin Exp Med 1997. [DOI: 10.1103/physrevd.55.7291] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|
250
|
Thyberg J, Blomgren K, Roy J, Tran PK, Hedin U. Phenotypic modulation of smooth muscle cells after arterial injury is associated with changes in the distribution of laminin and fibronectin. J Histochem Cytochem 1997; 45:837-46. [PMID: 9199669 DOI: 10.1177/002215549704500608] [Citation(s) in RCA: 118] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/04/2023] Open
Abstract
Earlier in vitro studies suggest opposing roles of laminin and fibronectin in regulation of differentiated properties of vascular smooth muscle cells. To find out if this may also be the case in vivo, we used immunoelectron microscopy to study the distribution of these proteins during formation of intimal thickening after arterial injury. In parallel, cell structure and content of smooth muscle alpha-actin was analyzed. The results indicate that the cells in the normal media are in a contractile phenotype with abundant alpha-actin filaments and an incomplete basement membrane. Within 1 week after endothelial denudation, most cells in the innermost layer of the media convert into a synthetic phenotype, as judged by loss of actin filaments, construction of a large secretory apparatus, and destruction of the basement membrane. Some of these cells migrate through fenestrae in the internal elastic lamina and invade a fibronectin-rich network deposited on its luminal surface. Within another few weeks a thick neointima forms, newly produced matrix components replace the stands of fibronectin, and a basement membrane reappears. Simultaneously, the cells resume a contractile phenotype, recognized by disappearance of secretory organelles and restoration of alpha-actin filaments. These findings support the notion that laminin and other basement membrane components promote the expression of a differentiated smooth muscle phenotype, whereas fibronectin stimulates the cells to adopt a proliferative and secretory phenotype.
Collapse
|